Abstract

Atracurium Besylate 10-mg/mL Injection, Preserved

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2014 - Volume 18, Number 4

Page(s): 322

Download in electronic PDF format for $75
  • Atracurium Besylate 10-mg/mL Injection, Preserved Page 1

Abstract

A formulation for preparing Atracurium Besylate 10-mg/mL Injection, Preserved. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • atracurium besylate
  • formulation
  • compounded sterile preparations
  • parenteral administration
  • skeletal muscle relaxant

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • PARENTERALS
  • STERILE PREPARATIONS
  • MUSCULOSKELETAL DISORDERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2014
Pg. 322
Atracurium Besylate 10-mg/mL Injection, Preserved
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 1998
Pg. 79-82
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion
Author(s): Bhatt-Mehta Varsha, Hirata Stacy
Jan/Feb 2021
Pg. 43
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 219-228
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 429
Amlodipine Besylate 1 mg/mL Veterinary Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Nov/Dec 2019
Pg. 519-527
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt
Author(s): Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
Nov/Dec 2023
Pg. 483-486
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 507
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 313
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Author(s): Allen Loyd V Jr
May/Jun 2023
Pg. 223-229
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank
Jul/Aug 2013
Pg. 270-280
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
Mar/Apr 2014
Pg. 147
Rocuronium Bromide 10-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 313-317
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Author(s): Allen Loyd V Jr